Recent Advances in the Treatment of Hereditary ATTR Amyloidosis (hATTR)

home / peer-exchange / recent-advances-in-the-treatment-of-hereditary-attr-amyloidosis-hattr

Key insight into treating ATTR Amyloidosis, including the use of new therapeutic options to provide a practical perspective on how recent data may apply to your clinical practice.

EP. 1: Overview of hATTR Amyloidosis

John L. Berk, MD;P. James B. Dyck, MD;Michael J. Polydefkis, MD;Thomas H. Brannagan III, MD;Ronald Witteles, MD

March 12th 2021

Video

Panelists offer an overarching view into hereditary ATTR amyloidosis and differentiate the condition from wild-type ATTR amyloidosis.

EP. 2: Prevalence of hATTR Amyloidosis

John L. Berk, MD;P. James B. Dyck, MD;Michael J. Polydefkis, MD;Thomas H. Brannagan III, MD;Ronald Witteles, MD

March 12th 2021

Video

Analysis on the prevalence of hereditary ATTR amyloidosis.

EP. 3: Disparities in Prevalence of hATTR Amyloidosis

John L. Berk, MD;P. James B. Dyck, MD;Michael J. Polydefkis, MD;Thomas H. Brannagan III, MD;Ronald Witteles, MD

March 19th 2021

Video

A discussion on understanding the disparities of race and gender in hereditary ATTR amyloidosis.

EP. 4: Signs and Symptoms of hATTR Amyloidosis

John L. Berk, MD;P. James B. Dyck, MD;Michael J. Polydefkis, MD;Thomas H. Brannagan III, MD;Ronald Witteles, MD

March 19th 2021

Video

Signs and symptoms to help determine a diagnosis of hereditary ATTR.

EP. 5: Diagnosing hATTR Amyloidosis

John L. Berk, MD;P. James B. Dyck, MD;Michael J. Polydefkis, MD;Thomas H. Brannagan III, MD;Ronald Witteles, MD

March 26th 2021

Video

Understanding the diagnostic process in making a ATTR amyloidosis diagnosis.

EP. 6: Diabetes and hATTR Amyloidosis Neuropathy

John L. Berk, MD;P. James B. Dyck, MD;Michael J. Polydefkis, MD;Thomas H. Brannagan III, MD;Ronald Witteles, MD

March 26th 2021

Video

Panelists suggest how to differentiate between diabetic neuropathy and ATTR amyloidosis.

EP. 7: Diagnostic Strategies in hATTR Amyloidosis

John L. Berk, MD;P. James B. Dyck, MD;Michael J. Polydefkis, MD;Thomas H. Brannagan III, MD;Ronald Witteles, MD

April 2nd 2021

Video

Diagnostic criteria commonly used to ensure an accurate diagnosis of hereditary ATTR amyloidosis is dissected.

EP. 8: Genetic Testing in hATTR Amyloidosis

John L. Berk, MD;P. James B. Dyck, MD;Michael J. Polydefkis, MD;Thomas H. Brannagan III, MD;Ronald Witteles, MD

April 2nd 2021

Video

Expert panelists provide recommendations for gene panel testing with genetic counseling for evaluation of patients with hereditary ATTR amyloidosis.

EP. 9: Tissue Biopsies in hATTR Amyloidosis

John L. Berk, MD;P. James B. Dyck, MD;Michael J. Polydefkis, MD;Thomas H. Brannagan III, MD;Ronald Witteles, MD

April 9th 2021

Video

Various types of biopsies to diagnosis hereditary ATTR amyloidosis are discussed.

EP. 10: Identification of the Amyloid Protein

John L. Berk, MD;P. James B. Dyck, MD;Michael J. Polydefkis, MD;Thomas H. Brannagan III, MD;Ronald Witteles, MD

April 9th 2021

Video

The use of mass spectrometry is the gold standard in amyloid proteins.

EP. 11: Recent Advances in hATTR Amyloidosis Treatment

John L. Berk, MD;P. James B. Dyck, MD;Michael J. Polydefkis, MD;Thomas H. Brannagan III, MD;Ronald Witteles, MD

April 16th 2021

Video

Treatment overview of hereditary ATTR amyloidosis and considerations for using newer therapies such as patisiran or inotersen in appropriate patients.